Nebius Stock: A 571% Sales Surge, a $27 Billion Capex Bill, and a 2027 Calendar That Now Sets the Price
Published on 11/16/2026 at 08:20 | Editorial boerse-global.deNebius can point to one of the fastest growth curves in the listed AI complex and still watch its shares fall. On Friday the stock moved -9.6% on the day, caught in a broad selloff across AI names and neocloud providers. Reuters tied the pressure to financing concerns following the departure of Nvidia CEO Jensen Huang, and Nebius — one of the Nvidia-backed companies — was among those swept up. Company-specific strain and sector-wide headwinds arrived at the same time.
The uncomfortable part sits in the gap between ambition and delivery. A revenue plan and the data center capacity needed to serve it are not the same thing, and investors are now pricing the difference. Nebius said with Thursday's release that expected revenue tied to delayed third-party data center capacity is slipping into early next year. Full-year 2026 revenue is therefore expected at the low end of its $3.0–3.4 billion range.
That reads like a timing issue. For shareholders it is anything but incidental: execution risk lives precisely between a growth announcement and its realization. What matters is not only what Nebius intends to reach, but when the capacity behind it actually starts generating revenue.
New Jersey Puts a Date on the Delay
The calendar becomes concrete at the New Jersey site. The remaining capacity contracted with Microsoft is scheduled for the second quarter of 2027. The site partner had begun scaling back temporary power generation. "Capacity delay" thus acquires a physical meaning: technical availability and electricity supply set the economic timetable.
Should investors sell immediately? Or is it worth buying Nebius?
Against that backdrop, the mandatory disclosures published Friday show how strong the underlying business already is. Third-quarter 2026 revenue rose 571% year over year to $980.8 million. Vigorous growth and mounting skepticism are not mutually exclusive — a high growth rate is no substitute for a credible schedule.
Nebius also raised expected capital expenditure for 2026 to roughly $27 billion on Thursday, and for the first time held out revenue of $12–13 billion for 2027. Those figures still describe a major step up. They also make execution more important, not less.
Two Brokers, One Bottleneck, Different Verdicts
Friday's analyst responses expose the tension. Baird cut its price target on Nebius from $340 to $200, according to media reports, while keeping its Outperform rating. The firm cited delays in data center capacity. A lower target need not mean abandoning the growth thesis — it can simply mean judging its realization more cautiously, and Baird's reassessment was sharp without touching the recommendation.
D.A. Davidson took a more guarded line. Analyst Gil Luria lowered his target from $250 to $125, according to media reports, and kept the rating at Neutral. He pointed to data center delays and the revised timeline for annual recurring revenue.
Both houses reacted to the same bottleneck and still reached different investment conclusions. That is more telling than a bare list of trimmed targets: the debate is not only about growth, but about which valuation standard delayed execution justifies.
The takeaway is that sector confidence and operational reliability are tightly bound together at Nebius. Financing worries across the AI sector supply the headwind; timely capacity delivery is the company's own test. Any convincing read on the stock has to hold both — rather than treating revenue ambitions as growth already banked.
Ad
Nebius Stock: New Analysis - 16 November
Fresh Nebius information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
